United States · 
Who invested in 9amHealth?
9amHealth's investors include Founders Fund, Speedinvest, Human Capital, Cigna Ventures and Catalio Capital Management, and 3 more on record.
202420252026
$9.5MSeries A$26MSeries B
United States · Series B startup
Who invested in 9amHealth
Funding summaryUpdated 26 Oct 2026
$36Mraised across 2 rounds since 2024, from 3 sources
$9.5MSeries A$26MSeries B
- Latest round
- Series B, $26MMay 2026
- Step-upi
- 2.7×
- Investors
- 8 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $9.5M Feb 2024
- Biggest round
- $26M Series B · May 2026
- Between rounds
- 2.3 years from the last two
The rounds
- May 2026Series B$26M1 new3 returning
Source recordedSEC filing: $26M sold
- Feb 2024Series A$9.5M7 new
Reported by Cigna Ventures and 1 otherSEC filing: $9.6M sold, first sale Jan 2024
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about 9amHealth
How much has 9amHealth raised?
9amHealth has raised $36M across 2 rounds since 2024.
When did 9amHealth last raise?
9amHealth's most recent round was a Series B of $26M in May 2026.
What was 9amHealth's biggest round?
Its most recent round, $26M in May 2026, is also its largest on record.
Who backed 9amHealth first?
9amHealth's first round on record, in Feb 2024, was backed by Cigna Ventures, Founders Fund and Speedinvest and 4 others.
What stage is 9amHealth at?
9amHealth's latest named round is a Series B, in May 2026.
Where is 9amHealth based?
9amHealth is based in the United States.
Who led 9amHealth's rounds?
Cigna Ventures led the Series A in 2024.
Companies like 9amHealth
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.